Decreased plasma half-life of cyclophosphamide during repeated high-dose administration (Q71761531)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

title

Decreased plasma half-life of cyclophosphamide during repeated high-dose administration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

author name string

M I Graham

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

I C Shaw

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

R L Souhami

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

B Sidau

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

P G Harper

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

A E McLean

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 January 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

192-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

Intensive cyclophosphamide (NSC-26271) therapy for solid tumors

21 October 2019

cites work

1 reference

12 December 2020

High-dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus

1 reference

12 December 2020

Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens

1 reference

12 December 2020

Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy

1 reference

12 December 2020

Denaturation of cytochrome P-450 by cyclophosphamide metabolites

1 reference

12 December 2020

Pharmacokinetics of cyclophosphamide in man

1 reference

12 December 2020

Clinical pharmacology of cyclophosphamide

1 reference

12 December 2020

Decreased half life of cyclophosphamide in patients under continual treatment

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00255760

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6861264 AND SRC:MED&resulttype=core&format=json

21 October 2019

1 reference